1. Home
  2. ELTX vs KUKE Comparison

ELTX vs KUKE Comparison

Compare ELTX & KUKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • KUKE
  • Stock Information
  • Founded
  • ELTX 2011
  • KUKE 2002
  • Country
  • ELTX United States
  • KUKE China
  • Employees
  • ELTX N/A
  • KUKE N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • KUKE Other Consumer Services
  • Sector
  • ELTX Health Care
  • KUKE Real Estate
  • Exchange
  • ELTX Nasdaq
  • KUKE Nasdaq
  • Market Cap
  • ELTX 49.7M
  • KUKE 49.8M
  • IPO Year
  • ELTX 2021
  • KUKE 2021
  • Fundamental
  • Price
  • ELTX $4.16
  • KUKE $0.90
  • Analyst Decision
  • ELTX Buy
  • KUKE
  • Analyst Count
  • ELTX 2
  • KUKE 0
  • Target Price
  • ELTX $10.00
  • KUKE N/A
  • AVG Volume (30 Days)
  • ELTX 16.1K
  • KUKE 834.1K
  • Earning Date
  • ELTX 11-07-2024
  • KUKE 11-05-2024
  • Dividend Yield
  • ELTX N/A
  • KUKE N/A
  • EPS Growth
  • ELTX N/A
  • KUKE N/A
  • EPS
  • ELTX N/A
  • KUKE N/A
  • Revenue
  • ELTX N/A
  • KUKE $14,784,158.00
  • Revenue This Year
  • ELTX N/A
  • KUKE N/A
  • Revenue Next Year
  • ELTX N/A
  • KUKE N/A
  • P/E Ratio
  • ELTX N/A
  • KUKE N/A
  • Revenue Growth
  • ELTX N/A
  • KUKE N/A
  • 52 Week Low
  • ELTX $2.96
  • KUKE $0.47
  • 52 Week High
  • ELTX $11.45
  • KUKE $4.07
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 40.82
  • KUKE 56.06
  • Support Level
  • ELTX $4.05
  • KUKE $0.47
  • Resistance Level
  • ELTX $4.89
  • KUKE $1.00
  • Average True Range (ATR)
  • ELTX 0.28
  • KUKE 0.16
  • MACD
  • ELTX -0.06
  • KUKE 0.03
  • Stochastic Oscillator
  • ELTX 27.37
  • KUKE 84.92

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About KUKE Kuke Music Holding Limited

Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.

Share on Social Networks: